Annandale, VA; January 6, 2021
Update in the Fight Against COVID-19
On December 11, 2020 the FDA gave its official EUA (Emergency Use Authorization) for the Pfizer COVID-19 vaccine.
It is important to keep in mind the fight doesn’t end with the EUA. Months of ongoing monitoring and study of volunteers’ medical status is essential to understanding the full range of effectiveness for the vaccine. This on-going nature is a normal part of virtually every clinical research study.
Very recently, On December 31, 2020, a senior director in Pfizer’s vaccine clinical research and development group announced, “We recognize that our clinical trial participants are selfless volunteers who have made the important choice to make a difference and fight this pandemic. While the study continues to be blinded to answer important public health questions…we are committed to ensuring that our trial participants are recognized for their contributions and that placebo recipients who wish can receive BNT162b2 within the study.”